$ILMN Recent Headlines Apple shares rise past $100

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ILMN Recent Headlines

Apple shares rise past $100 after Street beat 5:20 p.m. Oct. 20, 2014 - Wallace Witkowski
During times like these, cash is king 1:04 p.m. Oct. 2, 2014 - The Trading Deck
Two tech stocks with big potential 1:15 p.m. Sept. 11, 2014 - The Trading Deck
More reasons to like the Nasdaq in September 2:14 p.m. Sept. 4, 2014 - The Trading Deck
Good times for stocks lie ahead 12:47 p.m. Aug. 28, 2014 - The Trading Deck
Roche to buy InterMune for $8.3 billion 9:42 p.m. Aug. 24, 2014 - Jonathan D. Rockoff
Raiffeisen rallies, miners slip: Europe movers 11:04 a.m. Aug. 21, 2014 - Sara Sjolin
Miners drop in London after weak China PMI 11:02 a.m. Aug. 21, 2014 - Sara Sjolin
Nasdaq needs to turn up the volume 10:59 a.m. July 17, 2014 - The Trading Deck
Growth stocks are doing most bullish thing they can 2:24 p.m. July 1, 2014 - The Trading Deck
S&P, Dow press uncharted territory 7:22 a.m. June 23, 2014 - Michael Ashbaugh
Stocks are poised for a jump higher 11:30 a.m. June 10, 2014 - The Trading Deck
What Apple needs next is this 12:28 p.m. May 8, 2014 - Cody Willard
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
Let Ilumina brighten up your portfolio 3:02 p.m. Jan. 30, 2014 - The Trading Deck
Illumina gets mileage out of earnings as industry declines 10:51 a.m. Jan. 29, 2014 - Russ Britt
Illumina shares up on plan to tap $20 billion gene-sequencing market 12:06 p.m. Jan. 17, 2014 - Russ Britt
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 4:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
S&P, Nasdaq rally from major support 11:09 a.m. Dec. 16, 2013 - Michael Ashbaugh


IBD 50 Caps Impressive 2-Week Rally 5:47 p.m. Oct. 31, 2014 - Investors Business Daily
Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog 3:30 p.m. Oct. 31, 2014 - Zacks.com
Illumina (ILMN) Hits New Lifetime High 9:47 a.m. Oct. 31, 2014 - TheStreet.com
Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape 9:46 a.m. Oct. 31, 2014 - Zacks.com
Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% - Tale of the Tape 9:39 a.m. Oct. 31, 2014 - Zacks.com
Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% - Tale of the Tape 8:51 a.m. Oct. 31, 2014 - Zacks.com
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog 2:50 p.m. Oct. 30, 2014 - Zacks.com
Cara Therapeutics (CARA) Worth Watching: Stock Rises 6.4% - Tale of the Tape 9:39 a.m. Oct. 30, 2014 - Zacks.com
Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape 9:25 a.m. Oct. 30, 2014 - Zacks.com
ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8% - Tale of the Tape 8:51 a.m. Oct. 30, 2014 - Zacks.com
10-Q: ILLUMINA INC 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Illumina's Break Could Be Investor's Gain 2:00 p.m. Oct. 29, 2014 - benzinga.com
The Medicines Company (MDCO) Jumps: Stock Gains 16.5% - Tale of the Tape 9:25 a.m. Oct. 29, 2014 - Zacks.com
Chipotle And Apple Suppliers Rise Among 5 Young Guns 7:02 a.m. Oct. 29, 2014 - Investors Business Daily
Gilead (GILD) Posts Weak Earnings; Stock Falls 4% After-Hours - Stocks in the News 11:58 p.m. Oct. 28, 2014 - Zacks.com
Novavax (NVAX) in Focus: Stock Rises 13% - Tale of the Tape 8:44 a.m. Oct. 28, 2014 - Zacks.com
Can Illumina (ILMN) Stock Continue to Grow Earnings? - Tale of the Tape 8:41 a.m. Oct. 28, 2014 - Zacks.com
Four Biotechs Lead Health Care Stocks In Big Cap 20 6:00 p.m. Oct. 27, 2014 - Investors Business Daily
ILMN: Buy Into Illumina’s Perfect Quarter 9:55 a.m. Oct. 27, 2014 - InvestorPlace.com


HTG Announces Completion of IVD Development and Supply Agreement With Illumina 7:03 a.m. Oct. 30, 2014 - Marketwired
Recognition, Product Enhancement, Marketing Approval, Upcoming Events, and Quarterly Earnings - Research Reports on Abbott, Illumina, Thermo Fisher, Intercept and Stryker 8:40 a.m. Oct. 22, 2014 - PR Newswire - PRF
Critical Alerts For GoPro, NQ Mobile, SunEdison, Illumina and Qihoo 360 Technology Released By InvestorsObserver 9:31 a.m. Oct. 21, 2014 - PR Newswire - PRF
Illumina Reports Record Financial Results for Third Quarter of Fiscal Year 2014 4:06 p.m. Oct. 20, 2014 - BusinessWire - BZX
Illumina Launches New Reagent Kits for HiSeq X Ten and HiSeq 2500 Systems 6:30 a.m. Oct. 17, 2014 - BusinessWire - BZX
Illumina Accelerator Announces Investment in Inaugural Startup Class 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Affordable Housing Project, Lawsuit Settlement, Drug Review, and Earnings Release Schedules - Research Reports on UnitedHealth, Bristol-Myers, Boston Scientific, Abbott and Illumina 8:55 a.m. Oct. 14, 2014 - PR Newswire - PRF
Illumina to Announce Third Quarter 2014 Financial Results on Monday, October 20, 2014 6:30 a.m. Oct. 6, 2014 - BusinessWire - BZX
AB SCIEX and Illumina Collaborate to Create World’s First Multi-omics Cloud-Computing Environment 6:30 a.m. Oct. 2, 2014 - BusinessWire - BZX
Critical Alerts For Discovery Communications, GlaxoSmithKline, Illumina, Teekay and Gulfport Energy Released By InvestorsObserver 9:31 a.m. Oct. 1, 2014 - PR Newswire - PRF
Project Update, Awards, Appointment, Product Launch, and Sponsorship - Research Reports on D.R. Horton, Mallinckrodt, Illumina, Ventas and Capital One Financial 8:30 a.m. Sept. 29, 2014 - PR Newswire - PRF
Human Identification Market Growing at 13.9% CAGR to 2018 2:20 p.m. Sept. 26, 2014 - PR Newswire - PRF
Life Sciences Tools and Services Equities Technical Data - PerkinElmer, Agilent Technologies, Bruker, Sequenom, and Illumina 8:50 a.m. Sept. 22, 2014 - PR Newswire - PRF
Illumina, Inc. (NASDAQ: ILMN) to Ring The NASDAQ Stock Market Opening Bell 10:00 a.m. Sept. 9, 2014 - GlobeNewswire
Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions 6:30 a.m. Sept. 8, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 9:20 a.m. Sept. 3, 2014 - PR Newswire - PRF
Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference 6:30 a.m. Aug. 27, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Molecular Biology Enzymes, Kits, & Reagents Market by Application (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing), Product (Ligase, Phosphatase, Polymerase, Protease, Restriction Endonuclease, Reverse Transcriptase)-Global Forecast to 2018 6:02 p.m. Aug. 25, 2014 - PR Newswire - PRF
The Global Non-Invasive Prenatal Diagnostics Market 1:12 p.m. Aug. 19, 2014 - PR Newswire - PRF

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cannabis Industry Pushes for Robust Financial Services

Updated Category News Views 4

Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 4

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Atli Launches: AI-Powered eSIM Revolutionizes Travel

Updated Category News Views 5

What's New in Travel Tech: Atli's Debut Wandering the globe might sound romantic until you realize your phone's a paperweight without the right data. Enter Atli, a shiny new AI-powered travel eSIM service, snugged right into your WhatsApp. This marvel comes from the folks at XForge Mobile and aims to obliterate the hassle of getting connected abroad. You know those...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Unpacking RAGEism: Power Dynamics in U.S. Policies

Updated Category News Views 3

Seeing Patterns in Crisis: Jackson and Flint When Jackson, Mississippi's latest water crisis hit the news, it wasn't the first time folks were left high and dry. No, this fiasco's got deep roots, and it resonates with another infamous case: Flint, Michigan. In Maya Rockeymoore Cummings' book, RAGEism, these are badge-worthy examples of 'Resource Hoarding' where government...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 5

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Insurance Bad Faith: Navigating California's Rigorous Laws

Updated Category News Views 4

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Meiji Seika Pharma Expands KOSTAIVE® Manufacturing In Japan

Updated Category News Views 394

Meiji Seika Pharma Enhances Manufacturing Capabilities Meiji Seika Pharma Co., Ltd., known for its commitment to healthcare, has recently received exciting approval to expand its manufacturing and marketing capabilities for the innovative self-amplifying mRNA vaccine, KOSTAIVE®. This decision marks a significant milestone for the company as it strengthens the local...

Continue Reading
OS Therapies Achieves Milestone in Osteosarcoma Treatment

Updated Category News Views 246

An Exciting Breakthrough in Osteosarcoma Treatment OS Therapies, Inc. (NYSE-A: OSTX), a pioneering biotechnology firm, has recently made waves in the oncology field by completing a Phase 2b clinical trial concerning its innovative treatment, OST-HER2. This trial aims to address the severe challenges faced by patients suffering from lung metastatic osteosarcoma - a rare...

Continue Reading
CEO Andy Byron Takes Leave Following Coldplay Concert Incident

Updated Category News Views 381

CEO Andy Byron Takes Leave Amidst Viral Coldplay Incident Astronomer CEO Andy Byron is currently on leave due to a controversial situation that unfolded during a Coldplay concert. A video that circulated online appears to show Byron embracing the company’s HR head, Kristin Cabot, which ignited a social media frenzy. The Viral Video's Impact The footage, which originated...

Continue Reading
Misunderstood Whiskey's Exciting Launch of Orange Blossom Bourbon

Updated Category News Views 234

Misunderstood Whiskey Launches Orange Blossom Bourbon Misunderstood Whiskey Co. has announced the launch of their eagerly awaited Orange Blossom Bourbon. This marks a significant milestone as it is the brand's first bourbon since it began in 2017. With this release, the company aims to revolutionize the flavored whiskey market by providing high-quality, infused options...

Continue Reading
Impact of Capital Flows on Emerging Markets: A Cautionary Analysis

Updated Category News Views 352

Capital Flow Challenges for Emerging Economies The dynamics of capital flows have become a significant topic of discussion lately, with emerging markets facing potential hurdles that could alter their financial landscape dramatically. Recent insights from JPMorgan, an influential investment bank, shed light on these pressing issues. As economic policies shift globally,...

Continue Reading